Oxford interrupts trial of AstraZeneca COVID vaccine in children and adolescents due to blood clotting problem
Astrazeneca PLC (NYSE: AZN) – Countries preparing to suspend AstraZeneca vaccine because of blood clotting problems
Single dose of AstraZeneca or Pfizer COVID-19 vaccine reduces risk of hospitalization by more than 80%, study shows
The AstraZeneca vaccine can reduce the spread by 67% – and protection remains after the 3-month dosing interval
The UK becomes the first country to launch the AstraZeneca-Oxford vaccine, while stricter blocks are imminent
AstraZeneca’s COVID-19 vaccine can be approved in the UK “just after Christmas” – said a leading Oxford scientist
